RespireRx Pharmaceuticals Inc.
RSPI · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $7 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $102 | $134 | $96 | $23 |
| Total Curr. Assets | $109 | $141 | $96 | $23 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $7 | $0 | $0 |
| Total NC Assets | $0 | $7 | $0 | $0 |
| Other Assets | $0 | -$7 | $0 | $0 |
| Total Assets | $109 | $141 | $96 | $23 |
| Liabilities | – | – | – | – |
| Payables | $4 | $0 | $0 | $5,724 |
| Short-Term Debt | $2,781 | $2,873 | $2,854 | $2,709 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$3 | $0 | $0 |
| Other Curr. Liab. | $9,276 | $9,334 | $9,433 | $3,296 |
| Total Curr. Liab. | $12,061 | $12,210 | $12,287 | $11,729 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $344 | $74 | $119 | $174 |
| Total NC Liab. | $344 | $74 | $119 | $174 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $12,405 | $12,284 | $12,406 | $11,903 |
| Equity | – | – | – | – |
| Pref Stock | $811 | $672 | $22 | $22 |
| Common Stock | $298 | $221 | $144 | $126 |
| Retained Earnings | -$177,564 | -$177,169 | -$176,488 | -$176,058 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $164,159 | $164,133 | $164,012 | $164,030 |
| Total Equity | -$12,296 | -$12,142 | -$12,310 | -$11,880 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $109 | $141 | $96 | $23 |
| Net Debt | $2,775 | $2,866 | $2,854 | $2,709 |